April 12, 2005 David Karp Chief Financial Officer Chemokine Therapeuties Corp. Vancouver, BC, V6T 1Z3 Canada VIA CAMPUS MAIL Dear Mr. Karp, Re: Amendment to License Agreement between UBC and Chemokine Therapeutics Corporation dated September 22, 1999...Chemokine Therapeutics Corp • April 26th, 2005 • Biological products, (no disgnostic substances)
Company FiledApril 26th, 2005 IndustryThis letter agreement is to amend the subject of the License. The parties hereby agree to amend the License by making the following changes: